Pencil-thin ependymal enhancement in neuromyelitis optica spectrum disorders-Reference-Cited by-同舟云学术

Pencil-thin ependymal enhancement in neuromyelitis optica spectrum disorders

Published:2011-12-19 Issue:7 Volume:18 Page:1050-1053
ISSN:1352-4585
Container-title:Multiple Sclerosis Journal
language:en
Short-container-title:Mult Scler

Author:

Banker Piyush¹,Sonni Smitha¹,Kister Ilya²,Loh John P³,Lui Yvonne W³

Affiliation:

1. Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA

2. NYU-MS Center, Department of Neurology, New York University School of Medicine, NY, USA

3. Department of Radiology, New York University School of Medicine, NY, USA

Abstract

AQP4 water channels are thought to be the target of autoimmune attack in neuromyelitis optica-spectrum disorders (NMOsd). AQP4 are highly expressed on ventricular ependyma. The objective of this study was to describe a novel pattern of linear, ‘pencil-thin’ enhancement of ventricular ependyma in NMOsd. We report two NMOsd patients with pencil-thin ependymal enhancement along the frontal and occipital horns of lateral ventricles. Differential diagnosis of ependymal enhancement should include NMOsd alongside with infectious and neoplastic etiologies. Pencil-thin ependymal enhancement may be a helpful radiological marker of NMOsd that can be used to differentiate this condition from multiple sclerosis.

Publisher

SAGE Publications

Subject

Neurology (clinical),Neurology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1352458511431730

Reference10 articles.

1. Neuromyelitis optica: An update

2. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica

3. Brain Abnormalities in Neuromyelitis Optica

4. Brain magnetic resonance imaging abnormalities in neuromyelitis optica

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenic role of autoantibodies at the ependyma in autoimmune disorders of the central nervous system;Frontiers in Cellular Neuroscience;2023-09-13

2. Cerebral enhancement in MOG antibody-associated disease;Journal of Neurology, Neurosurgery & Psychiatry;2023-05-23

3. Neuromyelitis Optica Spectrum Disorders: Clinical Perspectives, Molecular Mechanisms, and Treatments;Applied Sciences;2023-04-17

4. Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis;Journal of Neurology;2023-04-06

5. Ependyma: a new target for autoantibodies in neuromyelitis optica?;Brain Communications;2022-11-02